PLIN1相关家族性部分脂肪营养不良的诊断挑战
研究对法国国家罕见病参考中心转诊的携带PLIN1移码变异的脂肪营养不良和/或胰岛素抵抗患者进行组织学和分子学研究,在4个无关家庭的9例患者中鉴定出两种与表型共分离的杂合PLIN1移码变异,FPLD4典型表现包括青春期后部分脂肪萎缩、肌肉肥大、肢端肥大样特征、多囊卵巢综合征和/或多毛症及代谢并发症,皮下脂肪小叶结构紊乱伴纤维化和巨噬细胞浸润。结论提示部分PLIN1变异具有致病性,遗传咨询前需仔细评估每个变异的致病证据。
要点
- PLIN1移码变异可在4个家庭9例患者中与FPLD4表型共分离。
- FPLD4典型表现包括青春期后部分脂肪萎缩、肌肉肥大和代谢并发症。
- 遗传咨询前应仔细评估每个PLIN1变异的致病证据。
核心结论
- 部分FPLD4相关PLIN1变异具有致病性,但每个变异的致病证据需在遗传咨询前仔细评估。
研究设计与样本
- 对转诊至法国国家罕见病参考中心的脂肪营养不良和/或胰岛素抵抗且携带PLIN1移码变异的患者进行组织学和分子学研究。
主要发现
- 在4个无关家庭的9例患者中鉴定出两种与表型共分离的杂合PLIN1移码变异。
- FPLD4典型体征包括青春期后部分脂肪萎缩(严重程度可变)、肌肉肥大、肢端肥大样特征、多囊卵巢综合征和/或女性多毛症。
- 代谢并发症包括高甘油三酯血症、肝脏脂肪变性、胰岛素抵抗和糖尿病。
- 皮下脂肪小叶结构紊乱伴纤维化和巨噬细胞浸润。
临床怎么用
- 建议对携带PLIN1移码变异的患者进行详细家系调查和以脂肪组织为重点的检查。
- 建议对代谢演变进行随访。
- 早期诊断对优化疾病管理重要,遗传咨询前应仔细评估变异致病性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Heterozygous frameshift variants in PLIN1 encoding perilipin-1, a key protein for lipid droplet formation and triglyceride metabolism, have been implicated in familial partial lipodystrophy type 4 (FPLD4), a rare entity with only six families reported worldwide. The pathogenicity of other PLIN1 null variants identified in patients with diabetes and/or hyperinsulinemia was recently questioned because of the absence of lipodystrophy in these individuals and the elevated frequency of PLIN1 null variants in the general population. OBJECTIVES: To reevaluate the pathogenicity of PLIN1 frameshift variants owing to new data obtained in the largest series of patients with FPLD4. METHODS: We performed histological and molecular studies for patients referred to our French National Reference Center for Rare Diseases of Insulin Secretion and Insulin Sensitivity for lipodystrophy and/or insulin resistance and carrying PLIN1 frameshift variants. RESULTS: We identified two heterozygous PLIN1 frameshift variants segregating with the phenotype in nine patients from four unrelated families. The FPLD4 stereotypical signs included postpubertal partial lipoatrophy of variable severity, muscular hypertrophy, acromegaloid features, polycystic ovary syndrome and/or hirsutism, metabolic complications (e.g., hypertriglyceridemia, liver steatosis, insulin resistance, diabetes), and disorganized subcutaneous fat lobules with fibrosis and macrophage infiltration. CONCLUSIONS: These data suggest that some FPLD4-associated PLIN1 variants are deleterious. Thus, the evidence for the pathogenicity of each variant ought to be carefully considered before genetic counseling, especially given the importance of an early diagnosis for optimal disease management. Thus, we recommend detailed familial investigation, adipose tissue-focused examination, and follow-up of metabolic evolution.
引用
- Jéru I, Vantyghem MC, Bismuth E, et al. Diagnostic Challenge in PLIN1-Associated Familial Partial Lipodystrophy. J Clin Endocrinol Metab. 2019. PMID: 31504636. doi:10.1210/jc.2019-00849
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。